A novel mutation of RPGR in a Chinese family with X-linked retinitis pigmentosa
Author:
Corresponding Author:

Hui-Hui Sun and Lu Chen. Children’s Hospital of Hebei Province, Shijiazhuang 050000, Hebei Province, China. sunhuihui86@sina.com; chenluzzb@sina.com

Fund Project:

Supported by Natural Science Foundation of Hebei Province (No.H2021316006); Hebei Provincial the Ministry of Health Research Fund for Medical Sciences (No.20200638).

  • Article
  • | |
  • Metrics
  • |
  • Reference [30]
  • |
  • Related [20]
  • | | |
  • Comments
    Abstract:

    AIM: To identify potential mutations and elucidate the clinical findings of male patients and female carriers of X-linked retinitis pigmentosa (XLRP) in a Chinese family. METHODS: A four generation pedigree was collected that consisted of 20 individuals. Genomic DNA was extracted from peripheral blood, and then the target fragments were amplified by PCR and sequenced directly. In addition, all affected patients and female carriers underwent comprehensively ophthalmic evaluation. RESULTS: A novel mutation c.2865G>A p.W955X in RPGR gene was identified of this family, including four affected individuals and eight carriers. All male patients, aging from 7 to 31y, tended to have more various, even potentially deleterious clinical features of RP. At the same time, individuals with heterozygous mutations (carriers) manifested a wide spectrum of clinical features. Herein, only two male patients and three female carriers manifested pathological myopia (PM). Among the female carriers, half of subjects who harbor poor visual acuity suffered esotropia or exotropia. Additionally, 16.7% and 66.7% of carriers had abnormal electroretinogram (ERG) and fundus, respectively. CONCLUSION: In this study, a novel mutation of the RPGR gene is identified, which broadens the spectrum of RPGR mutations, and elaborates the relationship between genotype and phenotype.

    Reference
    1 Hamel C. Retinitis pigmentosa. Orphanet J Rare Dis 2006;1:40.
    2 Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet 2006;368(9549):1795-1809.
    3 Tee JJL, Smith AJ, Hardcastle AJ, Michaelides M. RPGR-associated retinopathy: clinical features, molecular genetics, animal models and therapeutic options. Br J Ophthalmol 2016;100(8):1022-1027.
    4 Campochiaro PA, Mir TA. The mechanism of cone cell death in retinitis pigmentosa. Prog Retin Eye Res 2018;62:24-37.
    5 Zhang ZM, Dai HH, Wang L, Tao TC, Xu J, Sun XW, Yang LP, Li GL. Novel mutations of RPGR in Chinese families with X-linked retinitis pigmentosa. BMC Ophthalmol 2019;19(1):240.
    6 Sharon D, Sandberg MA, Rabe VW, Stillberger M, Dryja TP, Berson EL. RP2 and RPGR mutations and clinical correlations in patients with X-linked retinitis pigmentosa. Am J Hum Genet 2003;73(5):1131-1146.
    7 Stone EM, Andorf JL, Whitmore SS, DeLuca AP, Giacalone JC, Streb LM, Braun TA, Mullins RF, Scheetz TE, Sheffield VC, Tucker BA. Clinically focused molecular investigation of 1000 consecutive families with inherited retinal disease. Ophthalmology 2017;124(9):1314-1331.
    8 Tsang SH, Sharma T. X-linked retinitis pigmentosa. Adv Exp Med Biol 2018;1085:31-35.
    9 Vervoort R, Lennon A, Bird AC, Tulloch B, Axton R, Miano MG, Meindl A, Meitinger T, Ciccodicola A, Wright AF. Mutational hot spot within a new RPGR exon in X-linked retinitis pigmentosa. Nat Genet 2000;25(4):462-466.
    10 Churchill JD, Bowne SJ, Sullivan LS, Lewis RA, Wheaton DK, Birch DG, Branham KE, Heckenlively JR, Daiger SP. Mutations in the X-linked retinitis pigmentosa genes RPGR and RP2 found in 8.5% of families with a provisional diagnosis of autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci 2013;54(2):1411-1416.
    11 Appelbaum T, Becker D, Santana E, Aguirre GD. Molecular studies of phenotype variation in canine RPGR-XLPRA1. Mol Vis 2016;22: 319-331.
    12 Chiang JPW, Lamey TM, Wang NK, Duan J, Zhou W, McLaren TL, Thompson JA, Ruddle J, De Roach JN. Development of high-throughput clinical testing of RPGR ORF15 using a large inherited retinal dystrophy cohort. Invest Ophthalmol Vis Sci 2018;59(11): 4434-4440.
    13 Levy SE, Boone BE. Next-generation sequencing strategies. Cold Spring Harb Perspect Med 2019;9(7):a025791.
    14 Zhang QH, Giacalone JC, Searby C, Stone EM, Tucker BA, Sheffield VC. Disruption of RPGR protein interaction network is the common feature of RPGR missense variations that cause XLRP. Proc Natl Acad Sci U S A 2019;116(4):1353-1360.
    15 Hong DH, Pawlyk BS, Adamian M, Sandberg MA, Li TS. A single, abbreviated RPGR-ORF15 variant reconstitutes RPGR function in vivo. Invest Ophthalmol Vis Sci 2005;46(2):435-441.
    16 Koyanagi Y, Akiyama M, Nishiguchi KM, et al. Genetic characteristics of retinitis pigmentosa in 1204 Japanese patients. J Med Genet 2019;56(10):662-670.
    17 Kurata K, Hosono K, Hayashi T, Mizobuchi K, Katagiri S, Miyamichi D, Nishina S, Sato M, Azuma N, Nakano T, Hotta Y. X-linked retinitis pigmentosa in Japan: clinical and genetic findings in male patients and female carriers. Int J Mol Sci 2019;20(6):E1518.
    18 Megaw RD, Soares DC, Wright AF. RPGR: Its role in photoreceptor physiology, human disease, and future therapies. Exp Eye Res 2015;138:32-41.
    19 Breuer DK, Yashar BM, Filippova E, et al. A comprehensive mutation analysis of RP2 and RPGR in a North American cohort of families with X-linked retinitis pigmentosa. Am J Hum Genet 2002;70(6):1545-1554.
    20 Fahim AT, Bowne SJ, Sullivan LS, Webb KD, Williams JT, Wheaton DK, Birch DG, Daiger SP. Allelic heterogeneity and genetic modifier loci contribute to clinical variation in males with X-linked retinitis pigmentosa due to RPGR mutations. PLoS One 2011;6(8):e23021.
    21 Sandberg MA, Rosner B, Weigel-Difranco C, Dryja TP, Berson EL. Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations. Invest Ophthalmol Vis Sci 2007;48(3): 1298-1304.
    22 Wu ZJ, Hiriyanna S, Qian HH, Mookherjee S, Campos MM, Gao C, Fariss R, Sieving PA, Li TS, Colosi P, Swaroop A. A long-term efficacy study of gene replacement therapy for RPGR-associated retinal degeneration. Hum Mol Genet 2015;24(14):3956-3970.
    23 Sheng XL, Li ZL, Zhang XF, Wang J, Ren HW, Sun YB, Meng RH, Rong WN, Zhuang WJ. A novel mutation in retinitis pigmentosa GTPase regulator gene with a distinctive retinitis pigmentosa phenotype in a Chinese family. Mol Vis 2010;16:1620-1628.
    24 Jones BW, Pfeiffer RL, Ferrell WD, Watt CB, Marmor M, Marc RE. Retinal remodeling in human retinitis pigmentosa. Exp Eye Res 2016;150:149-165.
    25 Sanchez Tocino H, Diez Montero C, Villanueva Gómez A, Lobo Valentin R, Montero-Moreno JA. Phenotypic high myopia in X-linked retinitis pigmentosa secondary to a novel mutation in the RPGR gene. Ophthalmic Genet 2019;40(2):170-176.
    26 Talib M, van Schooneveld MJ, Van Cauwenbergh C, et al. The spectrum of structural and functional abnormalities in female carriers of pathogenic variants in the RPGR gene. Invest Ophthalmol Vis Sci 2018;59(10):4123-4133.
    27 Nanda A, Salvetti AP, Clouston P, Downes SM, MacLaren RE. Exploring the variable phenotypes of RPGR carrier females in assessing their potential for retinal gene therapy. Genes (Basel) 2018;9(12):E643.
    28 Cehajic Kapetanovic J, McClements ME, Martinez-Fernandez de la Camara C, MacLaren RE. Molecular strategies for RPGR gene therapy. Genes (Basel) 2019;10(9):674.
    29 Cehajic-Kapetanovic J, Xue K, Martinez-Fernandez de la Camara C, et al. Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR. Nat Med 2020;26(3):354-359.
    30 Giacalone JC, Andorf JL, Zhang QH, et al. Development of a molecularly stable gene therapy vector for the treatment of RPGR-associated X-linked retinitis pigmentosa. Hum Gene Ther 2019;30(8):967-974.
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

Hui-Hui Sun, Jing-Cong Zhao, Su-Ling Yang,/et al.A novel mutation of RPGR in a Chinese family with X-linked retinitis pigmentosa. Int J Ophthalmol, 2022,15(9):1423-1430

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
Publication History
  • Received:February 10,2021
  • Revised:June 27,2022
  • Online: September 01,2022